202 related articles for article (PubMed ID: 11595192)
1. What have we learned about the biology of atherosclerosis? The role of inflammation.
Libby P
Am J Cardiol; 2001 Oct; 88(7B):3J-6J. PubMed ID: 11595192
[TBL] [Abstract][Full Text] [Related]
2. New insights into plaque stabilisation by lipid lowering.
Libby P; Aikawa M
Drugs; 1998; 56 Suppl 1():9-13; discussion 33. PubMed ID: 9740536
[TBL] [Abstract][Full Text] [Related]
3. [Dyslipidemia, atherosclerosis, and vulnerable plaques: the effect of atorvastatin on atherosclerosis and plaque structure].
Tokgözoğlu L
Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():11-6. PubMed ID: 19404045
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol lowering in atherosclerosis.
Brown WV
Am J Cardiol; 2000 Aug; 86(4B):29H-32H. PubMed ID: 11021253
[TBL] [Abstract][Full Text] [Related]
5. Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.
Zhou J; Chew M; Ravn HB; Falk E
Scand J Clin Lab Invest Suppl; 1999; 230():3-11. PubMed ID: 10389196
[TBL] [Abstract][Full Text] [Related]
6. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2465-72. PubMed ID: 25212234
[TBL] [Abstract][Full Text] [Related]
7. Macrophages and atherosclerotic plaque stability.
Libby P; Geng YJ; Aikawa M; Schoenbeck U; Mach F; Clinton SK; Sukhova GK; Lee RT
Curr Opin Lipidol; 1996 Oct; 7(5):330-5. PubMed ID: 8937525
[TBL] [Abstract][Full Text] [Related]
8. [The promise of statins].
Capurso A
Ital Heart J Suppl; 2001 Mar; 2(3):224-9. PubMed ID: 11307780
[TBL] [Abstract][Full Text] [Related]
9. Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma.
Aikawa M; Libby P
Ann N Y Acad Sci; 2000 May; 902():140-52. PubMed ID: 10865834
[TBL] [Abstract][Full Text] [Related]
10. Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography.
Mitsutake R; Miura S; Okamura K; Niimura H; Kawamura A; Saku K
Intern Med; 2007; 46(12):859-63. PubMed ID: 17575379
[TBL] [Abstract][Full Text] [Related]
11. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
[TBL] [Abstract][Full Text] [Related]
12. [Atheroma plaque stabilization: a new concept based on the dynamic biology of atherosclerosis].
Páramo JA; Orbe J; Rodríguez JA
Med Clin (Barc); 2003 Nov; 121(15):583-7. PubMed ID: 14622526
[TBL] [Abstract][Full Text] [Related]
13. Vulnerable plaque: pathobiology and clinical implications.
Kullo IJ; Edwards WD; Schwartz RS
Ann Intern Med; 1998 Dec; 129(12):1050-60. PubMed ID: 9867761
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
15. Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function.
Eshtehardi P; McDaniel MC; Dhawan SS; Binongo JN; Krishnan SK; Golub L; Corban MT; Raggi P; Quyyumi AA; Samady H
J Invasive Cardiol; 2012 Oct; 24(10):522-9. PubMed ID: 23043036
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms modifying atherosclerotic disease - from lipids to vascular biology.
Weissberg P
Atherosclerosis; 1999 Sep; 147 Suppl 1():S3-10. PubMed ID: 10575056
[TBL] [Abstract][Full Text] [Related]
17. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
18. What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?
Waters DD; Hsue PY
Am J Cardiol; 2001 Oct; 88(7B):7J-16J. PubMed ID: 11595193
[TBL] [Abstract][Full Text] [Related]
19. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
Shukla A; Sharma MK; Jain A; Goel PK
Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
[TBL] [Abstract][Full Text] [Related]
20. [New information on the pathophysiology of atherosclerosis].
Reiner Z; Tedeschi-Reiner E
Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
